Clinical trial
Intraocular Pressure and Tolerability Study of Preservative Free Bimatoprost 0.03% Unit Dose (BUDPF) or Preservative Free Latanoprost 0.005% Unit Dose (LUDPF) (Monoprost®) in Patients With Ocular Hypertension or Glaucoma: A Randomized, Single Masked, 3 Month Cross-over, Investigator Led, European Multicentre Trial (SPORT)
NCT01975714 is registered in ClinicalTrials.gov with Association for Innovation and Biomedical Research on Light and Image as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intraocular Pressure and Tolerability Study of Preservative Free Bimatoprost 0.03% Unit Dose (BUDPF) or Preservative Free Latanoprost 0.005% Unit Dose (LUDPF) (Monoprost®) in Patients With Ocular Hypertension or Glaucoma: A Randomized, Single Masked, 3 Month Cross-over, Investigator Led, European Multicentre Trial (SPORT)
- Lead sponsor
- Association for Innovation and Biomedical Research on Light and Image
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2013
- Completion date
- February 28, 2015
- Enrollment
- 67 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.